Activity Report 2020 Executive Summary


16 Jun 2021

GARDP was able to make remarkable progress in 2020 despite the challenges of the COVID-19 pandemic. The Activity Report 2020 Executive Summary provides an overview of the work of GARDP to develop and make accessible treatments for the drug-resistant infections posing the greatest threat to health.

CLICK HERE TO VIEW THE INTERACTIVE ACTIVITY REPORT 2020

A flipbook version of the Executive Summary is available to view below:


We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.